New members

En Carta Diagnostics

En Carta Diagnostics is revolutionizing Lyme diagnostics by transforming smartphones into PCR machines, for precise at-home testing.

En Carta Diagnostics is revolutionizing Lyme diagnostics by transforming smartphones into PCR machines, for precise at-home testing. Its patented synthetic biology technology enables lab-grade molecular diagnostics without specialized equipment or toxic waste. The company is committed to developing innovative molecular paper-based diagnostics to improve the decentralization of diagnostic tools and transform point-of-care diagnostics.

For more information: https://www.encarta.bio/